One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2019-128470
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 3 |
Affiliation: Vall d'Hebron Hospital Universitari, Hospital Universitario de Valme, Hospital Universitario La Paz, Centro de Investigación del Cáncer, Instituto de Investigación Biomédica de Salamanca, Hospital de Sant Pau, Hospital Universitario 12 De Octubre, Hospital Universitari i Politècnic La Fe, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Hospital Universitario Reina Sofía, Institut d'Investigació Biomédica de Bellvitge, Institut Català d'Oncologia, Duran i Reynals Hospital, INCLIVA Health Research Institute, Central University Hospital of Asturias, Hospital Universitario Son Espases, Hospital Universitario Fundación Jiménez Díaz, Marqués de Valdecilla University Hospital, Universidad de Cantabria, Instituto de Investigación Marqués de Valdecilla, Hospital Universitario Infanta Leonor, Hospital Universitario Puerta de Hierro Majadahonda, Hospital Virgen de la Salud
Preliminary Results of Ibrutinib Followed By Ofatumumab Consolidation in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL): GELLC7 Trials from the Spanish Group of CLL (GELLC)
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
